マーケットレポート詳細
マルチモーダルイメージングの世界市場：技術別、用途別2028年予測
Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT/FMT), Application (Oncology, Cardiology, Brain, Ophthalmology), End User (Hospitals, Diagnostic Centers, Academia, Research) & Region - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年9月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文213ページになります。
- 商品コード：MAM3383
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
マルチモーダルイメージングの世界市場規模は2023年で42億ドル、2028年に55億ドル、市場の平均年成長率は5.7%増加で推移すると見込んでいます。
レポートはマルチモーダルイメージングの世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（技術別市場、用途別市場、等）を中心に構成されています。また競合状況、主要企業情報（15社）、ファイブフォース分析、規制分析も加味し、マルチモーダルイメージング市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆マルチモーダルイメージングの世界市場予測2021-2028年
・市場規模(US$)
◆技術別、市場-2028年
・PET/CTシステム
・SPECT/CTシステム
・PET/MRシステム
・OCT/FMTシステム
・その他マルチモーダルイメージングシステム
※(市場規模US$)
◆用途別、市場-2028年
・腫瘍
・心臓病
・眼科
・脳神経
・研究
・その他用途
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・病院
・画像診断センター
・学術研究機関
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※地域別に技術別、用途別、エンドユーザー別の細分化データ掲載
※国別に、技術別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス
・ファイブフォース分析
・規制分析
・エコシステムマッピング
・バリューチェーン分析
・サプライチェーン分析
・特許分析
・ケーススタディ分析
・価格分析（地域別価格帯）
・競合状況
・市場シェア分析
◆マルチモーダルイメージングの主要企業プロフィール動向
・GE HEALTHCARE
・KONINKLIJKE PHILIPS NV
・キヤノンメディカルシステムズ株式会社
・SIEMENS HEALTHINEERS
・ZEISS GROUP
・BRUKER
・MEDISO LTD
・NEUSOFT CORPORATION
・INFRAREDX, INC (PART OF NIPRO CORPORATION)
・株式会社トプコン
・SHANGHAI UNITED IMAGING HEALTHCARE CO, LTD
・HEIDELBERG ENGINEERING
・SPECTRUM DYNAMICS MEDICAL
・MINFOUND MEDICAL SYSTEMS CO, LTD
・KINDSWAY BIOTECH
その他企業
・SOFIE BIOSCIENCES, INC
・REFLEXION MEDICAL, INC
・CUBRESA INC
・富士フイルムホールディングス株式会社
・POSITRON
・MR SOLUTIONS
・ALCON INC
・ESSILOR INSTRUMENTS USA
・株式会社ニデック
・ZIEMER OPHTHALMIC SYSTEMS AG
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE 25
1.3.1 MARKETS COVERED 25
1.3.2 GEOGRAPHICAL SEGMENTATION
1.4 YEARS CONSIDERED
1.5 CURRENCY
1.6 RESEARCH LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1 MULTIMODAL IMAGING MARKET: RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH 31
2.1.2.1 PRIMARY SOURCES
2.1.2.2 KEY INDUSTRY INSIGHTS
2.1.2.3 BREAKDOWN OF PRIMARIES
・ FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
・ FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
・ FIGURE 5 MARKET SIZE ESTIMATION FOR MULTIMODAL IMAGING: APPROACH 1 (COMPANY REVENUE ESTIMATION)
・ FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF SIEMENS HEALTHINEERS
2.2.1.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
2.2.1.3 MULTIMODAL IMAGING MARKET: TOP-DOWN APPROACH
2.2.1.4 APPROACH 3: CAGR PROJECTIONS
・ FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 DATA TRIANGULATION
・ FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ASSESSMENT
2.5 STUDY ASSUMPTIONS
2.6 GROWTH RATE ASSUMPTIONS
2.7 RISK ASSESSMENT
2.7.1 MULTIMODAL IMAGING MARKET: RISK ASSESSMENT
2.8 RECESSION IMPACT
3 EXECUTIVE SUMMARY
・ FIGURE 9 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
・ FIGURE 10 MULTIMODAL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 11 MULTIMODAL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 GEOGRAPHICAL SNAPSHOT OF MULTIMODAL IMAGING MARKET
4 PREMIUM INSIGHTS
4.1 MULTIMODAL IMAGING MARKET OVERVIEW
・ FIGURE 13 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE MARKET
4.2 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
・ FIGURE 14 PET/CT MULTIMODAL IMAGING SYSTEMS TO DOMINATE NORTH AMERICAN MARKET IN 2023
4.3 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 15 HOSPITALS TO DOMINATE ASIA PACIFIC MARKET IN 2023
4.4 EUROPE: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 16 ONCOLOGY SEGMENT TO DOMINATE EUROPEAN MARKET DURING FORECAST PERIOD
4.5 MULTIMODAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 17 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 18 MULTIMODAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 GROWING APPLICATIONS OF MULTIMODAL IMAGING SYSTEMS
5.2.1.2 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES
・ TABLE 1 TECHNOLOGICAL ADVANCEMENTS IN MULTIMODAL IMAGING SYSTEMS
5.2.1.3 AVAILABILITY OF FUNDING FOR RESEARCH
5.2.1.4 INCREASING ESTABLISHMENT OF HOSPITALS AND DIAGNOSTIC IMAGING CENTERS
5.2.2 RESTRAINTS
5.2.2.1 UNFAVORABLE HEALTHCARE REFORMS
5.2.2.2 HIGH CAPITAL AND OPERATIONAL COST
5.2.2.3 LACK OF ADEQUATE HEALTHCARE INFRASTRUCTURE
5.2.3 OPPORTUNITIES
5.2.3.1 AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE FOR SCANS
・ TABLE 2 CODES FOR SPECT/CT FUSION IMAGING (AS OF 2021)
・ TABLE 3 NATIONAL PET, PET/CT COVERAGE FOR ONCOLOGY (AS OF 2021)
5.2.3.2 INCREASING R&D INTO RADIOTRACERS
5.2.4 CHALLENGES
5.2.4.1 GROWING END-USER PREFERENCE FOR REFURBISHED EQUIPMENT
5.2.4.2 DEARTH OF TRAINED PROFESSIONALS
5.3 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 4 MULTIMODAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 REGULATORY TRENDS
5.4.1 REGULATORY TRENDS FOR MULTIMODAL IMAGING MARKET
5.5 REGULATORY ANALYSIS
5.5.1 NORTH AMERICA
5.5.1.1 US
・ TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
・ TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.1.2 CANADA
・ TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPE
5.5.3 ASIA PACIFIC
5.5.3.1 JAPAN
・ TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.5.3.2 CHINA
・ TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.5.3.3 INDIA
5.6 REIMBURSEMENT SCENARIO
・ TABLE 10 MEDICAL REIMBURSEMENT CPT CODES FOR MULTIMODAL IMAGING PROCEDURES IN US (AS OF 2021)
5.7 ECOSYSTEM MAPPING
5.8 VALUE CHAIN ANALYSIS
5.8.1 RESEARCH & PRODUCT DEVELOPMENT
5.8.2 RAW MATERIAL AND MANUFACTURING
5.8.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES
・ FIGURE 19 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.9 SUPPLY CHAIN ANALYSIS
5.9.1 PROMINENT COMPANIES
5.9.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.9.3 END USERS
・ TABLE 11 MULTIMODAL IMAGING MARKET: SUPPLY CHAIN ECOSYSTEM
・ FIGURE 20 MULTIMODAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS
5.10 PATENT ANALYSIS
・ FIGURE 21 PATENTS FOR PET/CT IMAGING SYSTEMS (JANUARY 2013–JULY 2023)
・ FIGURE 22 PATENTS FOR PET/MR IMAGING SYSTEMS (JANUARY 2013–JULY 2023)
・ FIGURE 23 PATENTS FOR SPECT/CT IMAGING SYSTEMS (JANUARY 2013–JULY 2023)
・ FIGURE 24 PATENTS FOR OCT IMAGING SYSTEMS (JANUARY 2013–JULY 2023)
5.11 TRADE ANALYSIS
5.11.1 MULTIMODAL IMAGING MARKET: TRADE ANALYSIS
・ TABLE 12 IMPORT DATA FOR MULTIMODAL IMAGING (HS CODE 901820), BY COUNTRY, 2018–2022 (USD)
・ TABLE 13 EXPORT DATA FOR MULTIMODAL IMAGING (HS CODE 901820), BY COUNTRY, 2018–2022 (USD)
5.12 KEY CONFERENCES AND EVENTS
・ TABLE 14 MULTIMODAL IMAGING MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025)
5.13 TECHNOLOGY ANALYSIS
5.14 CASE STUDY ANALYSIS
・ TABLE 15 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
・ TABLE 16 CASE STUDY 2: PROVIDING COMPREHENSIVE TRAINING PROGRAMS FOR EVOLVING MULTIMODAL IMAGING TECHNIQUES
5.15 PRICING ANALYSIS
・ TABLE 17 REGION-WISE PRICE RANGE FOR MULTIMODAL IMAGING SYSTEMS
6 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
・ TABLE 18 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
6.2 PET/CT SYSTEMS
6.2.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
・ TABLE 19 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 20 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 21 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021–2028 (USD MILLION)
6.3 SPECT/CT SYSTEMS
6.3.1 INCREASING APPLICATIONS OF SPECT/CT SYSTEMS TO DRIVE MARKET
・ TABLE 22 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 23 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 24 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021–2028 (USD MILLION)
6.4 PET/MR SYSTEMS
6.4.1 ADVANTAGES OFFERED OVER PET/CT SYSTEMS FOR DIAGNOSTIC PURPOSES TO PROPEL MARKET
・ TABLE 25 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 26 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 27 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021–2028 (USD MILLION)
6.5 OCT/FMT SYSTEMS
6.5.1 INCREASING APPLICATIONS IN RETINAL DISEASE DIAGNOSIS TO DRIVE MARKET
・ TABLE 28 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 29 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 30 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021–2028 (USD MILLION)
6.6 OTHER MULTIMODAL IMAGING SYSTEMS
・ TABLE 31 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 32 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 33 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021–2028 (USD MILLION)
7 MULTIMODAL IMAGING MARKET, BY APPLICATION
7.1 INTRODUCTION
・ TABLE 34 MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 ONCOLOGY
7.2.1 INCREASING DEMAND FOR EARLY AND ACCURATE CANCER DIAGNOSIS TO DRIVE MARKET
・ TABLE 35 MULTIMODAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
7.3 CARDIOLOGY 98
7.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE GROWTH
・ TABLE 36 MULTIMODAL IMAGING MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
7.4 OPHTHALMOLOGY
7.4.1 TECHNOLOGICAL INNOVATIONS IN OPHTHALMIC MULTIMODAL IMAGING SYSTEMS TO SUPPORT MARKET GROWTH
・ TABLE 37 MULTIMODAL IMAGING MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
7.5 BRAIN & NEUROLOGY
7.5.1 INCREASING INCIDENCE OF BRAIN & NEUROLOGICAL DISORDERS TO PROPEL ADOPTION OF MULTIMODAL IMAGING SYSTEMS
・ TABLE 38 MULTIMODAL IMAGING MARKET FOR BRAIN & NEUROLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
7.6 RESEARCH
7.6.1 CAPABILITY TO PROVIDE COMPREHENSIVE AND SYNERGISTIC INSIGHTS INTO COMPLEX PHENOMENA TO SUPPORT MARKET GROWTH
・ TABLE 39 MULTIMODAL IMAGING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
7.7 OTHER APPLICATIONS
・ TABLE 40 MULTIMODAL IMAGING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
8 MULTIMODAL IMAGING MARKET, BY END USER
8.1 INTRODUCTION
・ TABLE 41 MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS 106
8.2.1 HIGH PROCEDURAL VOLUMES TO ENSURE SUSTAINED DEMAND FOR MULTIMODAL IMAGING
・ TABLE 42 MULTIMODAL IMAGING MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
8.3 DIAGNOSTIC IMAGING CENTERS
8.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH
・ TABLE 43 MULTIMODAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2021–2028 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 GROWING AVAILABILITY OF RESEARCH GRANTS AND FUNDING TO DRIVE MARKET
・ TABLE 44 MULTIMODAL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 109
8.5 OTHER END USERS
・ TABLE 45 MULTIMODAL IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
9 MULTIMODAL IMAGING MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 46 MULTIMODAL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 RECESSION IMPACT 112
・ FIGURE 25 NORTH AMERICA: MULTIMODAL IMAGING MARKET SNAPSHOT
・ TABLE 47 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 48 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 49 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 50 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 US
9.2.2.1 RISING GERIATRIC POPULATION TO DRIVE MARKET
・ TABLE 51 US: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 GOVERNMENT INVESTMENTS TO SUPPORT MARKET GROWTH
・ TABLE 52 CANADA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.3 EUROPE
9.3.1 RECESSION IMPACT 118
・ TABLE 53 EUROPE: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 54 EUROPE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 55 EUROPE: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 56 EUROPE: MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 57 GERMANY: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 RISING NUMBER OF DIAGNOSTIC IMAGING CENTERS TO PROPEL MARKET
・ TABLE 58 FRANCE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.3.4 UK
9.3.4.1 GOVERNMENT INITIATIVES TO SUPPORT MARKET GROWTH
・ TABLE 59 UK: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 AVAILABILITY OF REIMBURSEMENT COVERAGE TO SUPPORT MARKET GROWTH
・ TABLE 60 ITALY: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 INCREASING PUBLIC FUNDING FOR CELL-BASED RESEARCH TO PROPEL MARKET
・ TABLE 61 SPAIN: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
・ TABLE 62 REST OF EUROPE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 RECESSION IMPACT 127
・ FIGURE 26 ASIA PACIFIC: MULTIMODAL IMAGING MARKET SNAPSHOT
・ TABLE 63 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 64 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 65 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 66 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 RAPIDLY GROWING GERIATRIC POPULATION TO PROPEL MARKET
・ TABLE 67 CHINA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 HIGH ADOPTION OF ADVANCED TECHNOLOGIES TO SUPPORT MARKET GROWTH
・ TABLE 68 JAPAN: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 RISING PREVALENCE OF VARIOUS CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 69 INDIA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 INCREASING INVESTMENTS IN RESEARCH TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH
・ TABLE 70 AUSTRALIA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.4.6 SOUTH KOREA
9.4.6.1 PRESENCE OF WELL-DEVELOPED HEALTHCARE SYSTEM TO PROPEL MARKET
・ TABLE 71 SOUTH KOREA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
・ TABLE 72 REST OF ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RECESSION IMPACT 136
・ TABLE 73 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 74 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 75 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 76 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.2 BRAZIL
9.5.2.1 FAVORABLE DEMOGRAPHIC CONDITIONS TO DRIVE MARKET
・ TABLE 77 BRAZIL: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 INCREASED MEDICAL TOURISM AND BETTER GOVERNMENT HEALTHCARE INITIATIVES TO DRIVE MARKET
・ TABLE 78 MEXICO: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
・ TABLE 79 REST OF LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING MEDICAL TOURISM TO DRIVE MARKET
9.6.2 RECESSION IMPACT 142
・ TABLE 80 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 81 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 82 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MULTIMODAL IMAGING MARKET
10.3 REVENUE SHARE ANALYSIS
・ FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MULTIMODAL IMAGING MARKET, 2020–2022
10.4 MARKET SHARE ANALYSIS
・ FIGURE 28 MARKET SHARE ANALYSIS OF TOP PLAYERS IN MULTIMODAL IMAGING MARKET, 2022
・ TABLE 83 MULTIMODAL IMAGING MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
10.5.1 STARS
10.5.2 EMERGING LEADERS 149
10.5.3 PERVASIVE PLAYERS 149
10.5.4 PARTICIPANTS
・ FIGURE 29 MULTIMODAL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
10.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS 151
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES 151
・ FIGURE 30 MULTIMODAL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
10.7 COMPETITIVE BENCHMARKING
・ TABLE 84 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
・ TABLE 85 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES
・ TABLE 86 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
10.8 COMPETITIVE SCENARIO AND TRENDS
・ TABLE 87 PRODUCT LAUNCHES, JANUARY 2020–JULY 2023
・ TABLE 88 DEALS, JANUARY 2020–JULY 2023
・ TABLE 89 OTHER DEVELOPMENTS, JANUARY 2020–JULY 2023
11 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS) *
11.1 KEY PLAYERS 160
11.1.1 GE HEALTHCARE
・ TABLE 90 GE HEALTHCARE: COMPANY OVERVIEW
・ FIGURE 31 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
11.1.2 KONINKLIJKE PHILIPS N.V.
・ TABLE 91 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
・ FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
11.1.3 CANON MEDICAL SYSTEMS CORPORATION
・ TABLE 92 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
・ FIGURE 33 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022)
11.1.4 SIEMENS HEALTHINEERS
・ TABLE 93 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
・ FIGURE 34 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
11.1.5 ZEISS GROUP
・ TABLE 94 ZEISS GROUP: COMPANY OVERVIEW
・ FIGURE 35 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2022)
11.1.6 BRUKER
・ TABLE 95 BRUKER: COMPANY OVERVIEW
・ FIGURE 36 BRUKER: COMPANY SNAPSHOT (2022)
11.1.7 MEDISO LTD.
・ TABLE 96 MEDISO LTD.: COMPANY OVERVIEW
11.1.8 NEUSOFT CORPORATION.
・ TABLE 97 NEUSOFT CORPORATION: COMPANY OVERVIEW
11.1.9 INFRAREDX, INC. (PART OF NIPRO CORPORATION)
・ TABLE 98 INFRAREDX, INC.: COMPANY OVERVIEW
・ FIGURE 38 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
11.1.10 TOPCON CORPORATION
・ TABLE 99 TOPCON CORPORATION: COMPANY OVERVIEW
・ FIGURE 39 TOPCON CORPORATION: COMPANY SNAPSHOT (2022)
11.1.11 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
・ TABLE 100 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW
11.1.12 HEIDELBERG ENGINEERING
・ TABLE 101 HEIDELBERG ENGINEERING: COMPANY OVERVIEW
11.1.13 SPECTRUM DYNAMICS MEDICAL
・ TABLE 102 SPECTRUM DYNAMICS MEDICAL: COMPANY OVERVIEW
11.1.14 MINFOUND MEDICAL SYSTEMS CO., LTD.
・ TABLE 103 MINFOUND MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW
11.1.15 KINDSWAY BIOTECH
・ TABLE 104 KINDSWAY BIOTECH: COMPANY OVERVIEW
11.2 OTHER COMPANIES
11.2.1 SOFIE BIOSCIENCES, INC.
11.2.2 REFLEXION MEDICAL, INC.
11.2.3 CUBRESA INC.
11.2.4 FUJIFILM CORPORATION
11.2.5 POSITRON
11.2.6 MR SOLUTIONS
11.2.7 ALCON INC.
11.2.8 ESSILOR INSTRUMENTS USA
11.2.9 NIDEK CO., LTD. 210
11.2.10 ZIEMER OPHTHALMIC SYSTEMS AG 210
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW, RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.